Jerzy Jakubowicz

1.3k total citations
58 papers, 931 citations indexed

About

Jerzy Jakubowicz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Jerzy Jakubowicz has authored 58 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 13 papers in Epidemiology. Recurrent topics in Jerzy Jakubowicz's work include Breast Cancer Treatment Studies (11 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Breast Lesions and Carcinomas (9 papers). Jerzy Jakubowicz is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Breast Lesions and Carcinomas (9 papers). Jerzy Jakubowicz collaborates with scholars based in Poland, Canada and Hungary. Jerzy Jakubowicz's co-authors include Paweł Blecharz, Marian Reinfuss, Piotr Skotnicki, Tomasz Walasek, Beata Sas-Korczyńska, J Kulpa, Jerzy Mituś, Wojciech M. Wysocki, Tomasz Byrski and Jan Lubiński and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Radiotherapy and Oncology.

In The Last Decade

Jerzy Jakubowicz

52 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerzy Jakubowicz Poland 15 325 295 270 248 174 58 931
Paweł Blecharz Poland 15 358 1.1× 309 1.0× 218 0.8× 288 1.2× 234 1.3× 72 1.0k
Kotaro Iijima Japan 18 503 1.5× 487 1.7× 183 0.7× 276 1.1× 117 0.7× 59 873
Shoshu Mitsuyama Japan 16 337 1.0× 293 1.0× 130 0.5× 216 0.9× 100 0.6× 82 737
Regan Fulton United States 17 664 2.0× 371 1.3× 253 0.9× 137 0.6× 250 1.4× 31 1.1k
Eleanor Cornford United Kingdom 17 253 0.8× 410 1.4× 243 0.9× 351 1.4× 65 0.4× 38 874
Darren Wheeler United States 15 262 0.8× 129 0.4× 164 0.6× 181 0.7× 167 1.0× 30 1.1k
D. Faverly Belgium 12 389 1.2× 679 2.3× 116 0.4× 551 2.2× 139 0.8× 32 1.1k
Merih Güray Türkiye 11 421 1.3× 435 1.5× 112 0.4× 290 1.2× 98 0.6× 22 843
Daniela Stramazzotti Italy 16 268 0.8× 124 0.4× 188 0.7× 81 0.3× 197 1.1× 43 894
Anna W. Poniecka United States 11 689 2.1× 832 2.8× 168 0.6× 439 1.8× 144 0.8× 16 1.4k

Countries citing papers authored by Jerzy Jakubowicz

Since Specialization
Citations

This map shows the geographic impact of Jerzy Jakubowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerzy Jakubowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerzy Jakubowicz more than expected).

Fields of papers citing papers by Jerzy Jakubowicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerzy Jakubowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerzy Jakubowicz. The network helps show where Jerzy Jakubowicz may publish in the future.

Co-authorship network of co-authors of Jerzy Jakubowicz

This figure shows the co-authorship network connecting the top 25 collaborators of Jerzy Jakubowicz. A scholar is included among the top collaborators of Jerzy Jakubowicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerzy Jakubowicz. Jerzy Jakubowicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryś, Janusz, et al.. (2025). The Assessment of Sentinel Lymph Node Mapping Methods in Endometrial Cancer. Journal of Clinical Medicine. 14(3). 676–676. 2 indexed citations
2.
Leszczyńska, Agnieszka, et al.. (2024). Cervical cancer in Poland — epidemiology, prevention, and treatment pathways. SHILAP Revista de lepidopterología. 21(6). 391–398. 3 indexed citations
3.
Mituś, Jerzy, et al.. (2018). Are patients with phyllodes tumor of the breast good candidates for breast conserving therapy? A single center experience. European Journal of Gynaecological Oncology. 39(4). 641–644. 2 indexed citations
4.
Jasiówka, Marek, Monika Sobol, Diana Hodorowicz‐Zaniewska, et al.. (2016). Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland. Hereditary Cancer in Clinical Practice. 14(1). 5–5. 33 indexed citations
5.
Niemiec, Joanna, et al.. (2015). Prognostic Role of Nodal Status and Clinically Asymptomatic Valvular Insufficiency in Patients with HER2-positive Breast Cancer Treated with Chemotherapy, Radiotherapy and Trastuzumab in an Adjuvant Setting.. PubMed. 35(7). 4063–72. 1 indexed citations
6.
Walasek, Tomasz, et al.. (2015). Current treatment options of brain metastases and outcomes in patients with malignant melanoma. Reports of Practical Oncology & Radiotherapy. 21(3). 271–277. 16 indexed citations
7.
Jakubowicz, Jerzy, et al.. (2015). Muscle-invasive bladder cancer treated with TURB followed by concomitant boost with small reduction of radiotherapy field with or without of chemotherapy. Reports of Practical Oncology & Radiotherapy. 21(1). 31–36. 4 indexed citations
8.
Sas-Korczyńska, Beata, et al.. (2015). Androgen receptor in male breast cancer. Polish Journal of Pathology. 4(4). 347–352. 9 indexed citations
9.
Mituś, Jerzy, Marian Reinfuss, Jerzy Jakubowicz, et al.. (2014). Malignant Phyllodes Tumor of the Breast: Treatment and Prognosis. The Breast Journal. 20(6). 639–644. 61 indexed citations
10.
Mucha-Małecka, Anna, et al.. (2014). Postoperative irradiation in patients with pT3-4N0 laryngeal cancer: results and prognostic factors. European Archives of Oto-Rhino-Laryngology. 272(3). 673–679. 11 indexed citations
11.
Blecharz, Paweł, Marian Reinfuss, Janusz Ryś, et al.. (2013). Radiotherapy for carcinoma of the vagina. Strahlentherapie und Onkologie. 189(5). 394–400. 11 indexed citations
12.
Biesaga, Beata, Sława Szostek, Małgorzata Klimek, Jerzy Jakubowicz, & Joanna Wysocka. (2012). Comparison of the sensitivity and specificity of real-time PCR and <i>in situ</i> hybridization in HPV16 and 18 detection in archival cervical cancer specimens. Folia Histochemica et Cytobiologica. 50(2). 239–247. 9 indexed citations
13.
Blecharz, Paweł, Krzysztof Urbański, Anna Mucha-Małecka, et al.. (2011). Hematogenous metastases in patients with Stage I or II endometrial carcinoma. Strahlentherapie und Onkologie. 187(12). 806–811. 13 indexed citations
14.
Reinfuss, Marian, Anna Mucha-Małecka, Tomasz Walasek, et al.. (2010). Palliative thoracic radiotherapy in non-small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicity. Lung Cancer. 71(3). 344–349. 42 indexed citations
15.
Jakubowicz, Jerzy, et al.. (2009). Uterine sarcomas - an evaluation of treatment results and prognostic factors. Archives of Medical Science. 5(2). 215–221. 1 indexed citations
16.
Skotnicki, Piotr, Janusz Ryś, Jerzy Jakubowicz, & Paweł Blecharz. (2008). Czy odmiana mikroskopowa inwazyjnego zrazikowego raka piersi ma znaczenie prognostyczne. 2(2). 17–21.
18.
Kojs, Zbigniew, et al.. (2006). Classical prognostic factors in patients with non-advanced endometrial cancer treated with postoperative radiotherapy. Reports of Practical Oncology & Radiotherapy. 11(4). 169–174. 1 indexed citations
19.
Klimek, Małgorzata, et al.. (2001). Rak trzonu macicy – wstępna ocena tolerancji pooperacyjnej pulsacyjnej brachyterapii. Reports of Practical Oncology & Radiotherapy. 6(2). 95–98.
20.
Klimek, Małgorzata, et al.. (2000). 5 Rak endometrium – wstępna ocena tolerancji pooperacyjnej pulsacyjnej brachyterapii. Reports of Practical Oncology & Radiotherapy. 5(1). 10–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026